Completed PHASE2/PHASE3 INTERVENTIONAL NCT00314379

Endothelial Function in a Sample Group of Patients From the ICARE Study

Vitamin E Treatment and Endothelial Function in Type 2 Diabetic Patients With Hp 2-2 Phenotype From the I CARE Study (EFI)

Sponsor: Clalit Health Services

Conditions Cardiovascular Diseases

Interventions Vitamin E 400IU/day

Updated 5 times since 2017 Last updated: Jan 20, 2009 Started: Apr 30, 2006 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Cardiovascular Diseases and is currently completed. Clalit Health Services leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clalit Health Services
Rambam Health Care Campus
Technion, Israel Institute of Technology

Data source: Technion, Israel Institute of Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Haifa, Israel